Karnati Konda Reddy

Karnati Konda Reddy

Auto-generated profile, based on publicly available information

Karnati Konda Reddy

Computer-Aided Drug Design and Molecular Modeling Lab, Department of Bioinformatics, Alagappa University, Karaikudi, Tamil Nadu, India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2018 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
KKKonda Reddy Karnati
Konda Reddy Karnati
YWYixuan Wang
Yixuan Wang
Two widely used anticancer drugs, doxorubicin (DOX) and paclitaxel (PTX), possess distinct physical properties and chemotherapy specificity. In order to investigate their interaction mechanism with single-walled carbon nanotubes (SWCNTs), co-loading and releasing from the SWCNTs, all-atom molecular dynamics (MD) simulations were firstly carried out for different SWCNT systems, followed by binding free energy calculation with MM-PBSA. The results indicate that the co-loading of DOX and PTX onto the pristine SWCNT is exothermic and spontaneous. The DOX molecules predominantly interact with the SWCNT via π–π stacking through the conjugated aromatic rings, while the separated aromatic rings of PTX also primarily interact with the SWCNT through π–π stacking yet supplemented by an X–π (X = C–H, N–H and CO) interaction. Moreover, the strongest binding of DOX and PTX with the pristine SWCNT shows similar strength (ΔG: −32.0 vs. −33.8 kcal mol−1). For the chitosan functionalized SWCNT (f-SWCNT), the DOX and PTX molecules still prefer binding to the sidewall of the CNT rather than binding with the polymer, and the non-covalent functionalization of the SWCNT with chitosan decreases the binding of DOX and PTX with the sidewall of the f-SWCNT as compared with the DOX/PTX–SWCNT system (ΔG: −24.0 and −21.9 kcal mol−1). The protonation of chitosan and drug molecules further weakens the interaction between DOX/PTX and the f-SWCNT, and shows a consequent displacement of the drug molecules, triggering the release of the drugs. The variation of binding strength of the three systems (DOX/PTX–SWCNT, DOX/PTX–f-SWCNT, and DOXH+/PTXH+–f-SWCNT) was also discussed in terms of the histogram or frequency of the distance from the drugs to the SWCNT. In addition, the encapsulation of two DOX molecules by the f-SWCNT is considerably stronger than the binding of the other six drug molecules to the sidewall, indicating that the encapsulation of anticancer drugs may also play a very important role and should be considered in the drug delivery.

25 March 2013 in Journal of Receptors and Signal Transduction
Verified
Journal Article
Closed access
KRKarnati Konda Reddy
Karnati Konda Reddy
SSSanjeev Kumar Singh
Sanjeev Kumar Singh
STSunil Kumar Tripathi
Sunil Kumar Tripathi
Chandrabose SelvarajChandrabose Selvaraj
Chandrabose Selvaraj
VSVenkatesan Suryanarayanan
Venkatesan Suryanarayanan
Sterol 14α-demethylase (CYP51) is a cytochrome P450 heme thiolate containing enzyme involved in biosynthesis of membrane sterols, including sterol in animals, ergosterol in fungi, and a variety of C24-modified sterols in plants and protozoa. Several clinical drugs have been developed to reduce the impact of fungal diseases, but their clinical uses have been limited by the emergence of drug resistance and insufficiencies in their antifungal activity. Therefore, in order to identify potential CYP51 inhibitors, we have implemented a virtual screening (VS) protocol by using both phase shape and pharmacophore model (AHHRR) against Asinex, ChemBridge and Maybridge databases. A filtering protocol, including Lipinski filter, number of rotatable bonds and different precisions of molecular docking was applied in hits selection. The results indicated that both shape-based and pharmacophore-based screening yielded the best result with potential inhibitors. The searched compounds were also evaluated with ADME properties, which show excellent pharmacokinetic properties under the acceptable range. We identified potential CYP51 inhibitors for further investigation, they could also be employed to design ligands with enhanced inhibitory potencies and to predict the potencies of analogs to guide synthesis/or prepare synthetic antifungal analogs against CYP51.

17 September 2012 in Journal of Molecular Recognition
Verified
Journal Article
Closed access
PDF file
STSunil Kumar Tripathi
Sunil Kumar Tripathi
SSSanjeev Kumar Singh
Sanjeev Kumar Singh
PSPoonam Singh
Poonam Singh
Chella Perumal PalanisamyChella Perumal Palanisamy
Chella Perumal Palanisamy
KRKarnati Konda Reddy
Karnati Konda Reddy
Chandrabose SelvarajChandrabose Selvaraj
Chandrabose Selvaraj

1 June 2011 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
KRKarnati Konda Reddy
Karnati Konda Reddy
SSSanjeev Kumar Singh
Sanjeev Kumar Singh
NDNigus Dessalew
Nigus Dessalew
STSunil Kumar Tripathi
Sunil Kumar Tripathi
Chandrabose SelvarajChandrabose Selvaraj
Chandrabose Selvaraj
Pharmacophore modelling and atom-based 3D-QSAR studies were carried out for a series of compounds belonging to N-methyl pyrimidones as HIV-1 integrase inhibitors. Based on the ligand-based pharmacophore model, we got 5-point pharmacophore model AADDR, with two hydrogen bond acceptors (A), two hydrogen bond donors (D) and one aromatic ring (R). The generated pharmacophore-based alignment was used to derive a predictive atom-based 3D-QSAR model for the training set (r2 = 0.92, SD = 0.16, F = 84.8, N = 40) and for test set (Q2 = 0.71, RMSE = 0.06, Pearson R = 0.90, N = 10). From these results, AADDR pharmacophore feature was selected as best common pharmacophore hypothesis, and atom-based 3D-QSAR results also support the outcome by means of favourable and unfavourable regions of hydrophobic and electron-withdrawing groups for the most potent compound 30. These results can be useful for further design of new and potent HIV-1 IN inhibitors.

25 March 2013 in SAR and QSAR in Environmental Research
Verified
Journal Article
Closed access
KRK.K. Reddy
K.K. Reddy
SSSanjeev Kumar Singh
Sanjeev Kumar Singh
STS.K. Tripathi
S.K. Tripathi
Chandrabose SelvarajChandrabose Selvaraj
Chandrabose Selvaraj
HIV-1 integrase (IN) is a retroviral enzyme that catalyses integration of the reverse-transcribed viral DNA into the host genome, which is necessary for efficient viral replication. In this study, we have performed an in silico virtual screening for the identification of potential HIV-1 IN strand transfer (ST) inhibitors. Pharmacophore modelling and atom-based 3D-QSAR studies were carried out for a series of compounds belonging to 3-Hydroxypyrimidine-2,4-diones. Based on the ligand-based pharmacophore model, we obtained a five-point pharmacophore with two hydrogen bond acceptors (A), one hydrogen bond donor (D), one hydrophobic group (H) and one aromatic ring (R) as pharmacophoric features. The pharmacophore hypothesis AADHR was used as a 3D query in a sequential virtual screening study to filter small molecule databases Maybridge, ChemBridge and Asinex. Hits matching with pharmacophore hypothesis AADHR were retrieved and passed progressively through Lipinski’s rule of five filtering, molecular docking and hierarchical clustering. The five compounds with best hits with novel and diverse chemotypes were subjected to QM/MM docking, which showed improved docking accuracy. We further performed molecular dynamics simulation and found three compounds that form stable interactions with key residues. These compounds could be used as a leads for further drug development and rational design of HIV-1 IN inhibitors.

8 January 2012 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
STSunil Kumar Tripathi
Sunil Kumar Tripathi
Chandrabose SelvarajChandrabose Selvaraj
Chandrabose Selvaraj
SSSanjeev Kumar Singh
Sanjeev Kumar Singh
KRKarnati Konda Reddy
Karnati Konda Reddy